Russell Investments Group, Ltd. Galapagos Nv Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$96.85 - $148.25 $635,142 - $972,223	-6,558 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$122.47 - $213.56 $943,876 - $1.65 Million	-7,707 Reduced 54.03%	6,558 $929,000
Q2 2020 Aug 05, 2020	SELL	$185.52 - $231.25 $112,610 - $140,368	-607 Reduced 4.08%	14,265 $2.8 Million
Q4 2019 Jan 29, 2020	BUY	$146.12 - $215.82 $2.17 Million - $3.21 Million	14,872 New	14,872 $3.1 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.